Related Experiment Video
Updated: Jun 13, 2025

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
Published on: January 26, 2024
Non-Coding RNAs in Peritoneal Carcinomatosis: From Bench to Bedside
Julia Bohosova1,2,3, Nida Sarosh Ashraf1,4, Ondrej Slaby2,3
1Translational Molecular Pathology Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Peritoneal carcinomatosis, an advanced cancer stage, is a fatal condition. This review explores the role of non-coding RNAs in its development and potential therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Peritoneal carcinomatosis is an advanced stage of cancer metastasis within the peritoneal cavity.
- It is often considered a terminal condition with a poor prognosis.
- Recent advancements highlight the importance of non-coding RNAs in cellular regulation and disease, particularly in cancer.
Purpose of the Study:
- To provide a comprehensive review of the current understanding of peritoneal carcinomatosis.
- To focus on the specific role of non-coding RNAs in the development of this condition.
- To identify potential future research directions and therapeutic targets.
Main Methods:
- Literature review of existing research on peritoneal carcinomatosis.
- Analysis of studies investigating non-coding RNA functions in cancer.
- Synthesis of findings to elucidate the connection between non-coding RNAs and peritoneal carcinomatosis.
Main Results:
- Non-coding RNAs play a critical role in regulating cellular processes relevant to cancer.
- Disruptions in non-coding RNA regulation are implicated in the development and progression of various cancers, including those in the peritoneal cavity.
- The specific involvement of different non-coding RNAs in peritoneal carcinomatosis is an emerging area of research.
Conclusions:
- Non-coding RNAs represent a promising area for understanding and potentially treating peritoneal carcinomatosis.
- Further research into non-coding RNA mechanisms is crucial for developing novel therapeutic strategies.
- Targeting non-coding RNAs may offer new avenues for managing this advanced cancer stage.
More Related Videos
08:56Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
Published on: June 27, 2017
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019